SynthesisChinese medical journal2026

Efficacy and safety of first-line treatments for metastatic castration-resistant prostate cancer based on phase II and III randomized controlled trials: A PROSTA-MAP systematic review and network meta-analysis.

Xuanjun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.